The University of Chicago Header Logo

Connection

Michael Becker to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Maximum Tolerated Dose.
Michael Becker
Connection Strength
0.048
Maximum Tolerated Dose
  1. A phase I study of decitabine and rapamycin in relapsed/refractory AML. Leuk Res. 2013 Dec; 37(12):1622-7.
    View in: PubMed
    Score: 0.026
  2. A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection. Biol Blood Marrow Transplant. 2011 Jul; 17(7):1033-42.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.